The Impact of a 12-week Virtual Buddy-movement Therapy on the Psychomotor and Social Development of Pediatric Oncology Patients in Remission

What this Trial Is About

Researchers are studying the effects of a 12-week virtual Buddy-movement therapy on the psychomotor and social development of children aged 5 to 12 years who are in remission from acute lymphoblastic leukemia (ALL). ALL is the most common cancer diagnosed in children between two and five years old and requires aggressive treatment that often separates children from their peers, negatively affecting their quality of life. This study aims to improve motor skills and quality of life, including emotional, social, physical, and school functioning, for pediatric cancer survivors. The study involves two groups: an experimental group that will participate in the 12-week Buddy-movement therapy twice a week for 60 minutes, and a control group that will maintain their usual routines without additional physical activity. The therapy uses integrative movement, psychomotor exercises, dance, and expressive sequences focused on developing fine and gross motor skills, hand coordination, body coordination, strength, and agility. The program is adapted to children's ages and specific needs. Participants will undergo assessments before and after the 12 weeks, including measurements of body mass index, waist and hip circumference, psychomotor skills using the Bruininks-Oseretsky Test of Motor Proficiency (BOT-2), and quality of life using the Pediatric Quality of Life Inventory (PedsQL). Researchers will compare changes in motor proficiency and quality of life between the groups. The study will monitor these outcomes to understand how the therapy affects physical and social development in pediatric ALL patients in remission.

Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission